Technetium-99m-Sestamibi Uptake in Myeloma
A number of reports describe how 99mTc-sestamibi detects benign and malignant primary and metastatic tumors. We report abnormal 99mTc-sestamibi uptake in nine sites in a 53-yr-old patient with histologically and biochemically proven IgG kappa-secreting myeloma. The 99mTc-sestamibi study was undertak...
Gespeichert in:
| Veröffentlicht in: | The Journal of nuclear medicine (1978) 1996-06, Vol.37 (6), p.1001-1002 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1002 |
|---|---|
| container_issue | 6 |
| container_start_page | 1001 |
| container_title | The Journal of nuclear medicine (1978) |
| container_volume | 37 |
| creator | Adams, Bruce K Fataar, Abdulbasier Nizami, Mohammad A |
| description | A number of reports describe how 99mTc-sestamibi detects benign and malignant primary and metastatic tumors. We report abnormal 99mTc-sestamibi uptake in nine sites in a 53-yr-old patient with histologically and biochemically proven IgG kappa-secreting myeloma. The 99mTc-sestamibi study was undertaken for an unrelated hyperparathyroidism. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78174489</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>25381907</sourcerecordid><originalsourceid>FETCH-LOGICAL-h265t-22bd3f4a1386aaa1dbb350a2941feff4d390f74ef6d56bb16d97e513ae88a0593</originalsourceid><addsrcrecordid>eNpd0EtLAzEUBeAgSq3VnyAUFwpCIO_HUoovqLiwXYekc-OkTmbqPJD-e6fYlau7OB-Hwz1BUyq5xFIpfYqmhCqKpSTyHF103ZYQoowxEzQxynBm6RTdr2BT1tCnIWNrM_6Arvc5hTRf73r_BfNUz9_2UDXZX6Kz6KsOro53htZPj6vFC16-P78uHpa4ZEr2mLFQ8Cg85UZ572kRApfEMytohBhFwS2JWkBUhVQhUFVYDZJyD8Z4Ii2fodu_3l3bfA_jHpdTt4Gq8jU0Q-e0oVoIc4A3_-C2Gdp63OYYtUxoTdiIro9oCBkKt2tT9u3eHT8w5nd_eZk-y5_UgquHTQW-PeBtnbl2ylFCKP8F3rxj7Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219247702</pqid></control><display><type>article</type><title>Technetium-99m-Sestamibi Uptake in Myeloma</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Adams, Bruce K ; Fataar, Abdulbasier ; Nizami, Mohammad A</creator><creatorcontrib>Adams, Bruce K ; Fataar, Abdulbasier ; Nizami, Mohammad A</creatorcontrib><description>A number of reports describe how 99mTc-sestamibi detects benign and malignant primary and metastatic tumors. We report abnormal 99mTc-sestamibi uptake in nine sites in a 53-yr-old patient with histologically and biochemically proven IgG kappa-secreting myeloma. The 99mTc-sestamibi study was undertaken for an unrelated hyperparathyroidism.</description><identifier>ISSN: 0161-5505</identifier><identifier>EISSN: 1535-5667</identifier><identifier>PMID: 8683291</identifier><identifier>CODEN: JNMEAQ</identifier><language>eng</language><publisher>United States: Soc Nuclear Med</publisher><subject>Female ; Humans ; Hyperplasia ; Immunoglobulin kappa-Chains - metabolism ; Middle Aged ; Multiple Myeloma - diagnostic imaging ; Multiple Myeloma - immunology ; Parathyroid Glands - diagnostic imaging ; Parathyroid Glands - pathology ; Radionuclide Imaging ; Technetium Tc 99m Sestamibi</subject><ispartof>The Journal of nuclear medicine (1978), 1996-06, Vol.37 (6), p.1001-1002</ispartof><rights>Copyright Society of Nuclear Medicine Jun 1996</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8683291$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adams, Bruce K</creatorcontrib><creatorcontrib>Fataar, Abdulbasier</creatorcontrib><creatorcontrib>Nizami, Mohammad A</creatorcontrib><title>Technetium-99m-Sestamibi Uptake in Myeloma</title><title>The Journal of nuclear medicine (1978)</title><addtitle>J Nucl Med</addtitle><description>A number of reports describe how 99mTc-sestamibi detects benign and malignant primary and metastatic tumors. We report abnormal 99mTc-sestamibi uptake in nine sites in a 53-yr-old patient with histologically and biochemically proven IgG kappa-secreting myeloma. The 99mTc-sestamibi study was undertaken for an unrelated hyperparathyroidism.</description><subject>Female</subject><subject>Humans</subject><subject>Hyperplasia</subject><subject>Immunoglobulin kappa-Chains - metabolism</subject><subject>Middle Aged</subject><subject>Multiple Myeloma - diagnostic imaging</subject><subject>Multiple Myeloma - immunology</subject><subject>Parathyroid Glands - diagnostic imaging</subject><subject>Parathyroid Glands - pathology</subject><subject>Radionuclide Imaging</subject><subject>Technetium Tc 99m Sestamibi</subject><issn>0161-5505</issn><issn>1535-5667</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpd0EtLAzEUBeAgSq3VnyAUFwpCIO_HUoovqLiwXYekc-OkTmbqPJD-e6fYlau7OB-Hwz1BUyq5xFIpfYqmhCqKpSTyHF103ZYQoowxEzQxynBm6RTdr2BT1tCnIWNrM_6Arvc5hTRf73r_BfNUz9_2UDXZX6Kz6KsOro53htZPj6vFC16-P78uHpa4ZEr2mLFQ8Cg85UZ572kRApfEMytohBhFwS2JWkBUhVQhUFVYDZJyD8Z4Ii2fodu_3l3bfA_jHpdTt4Gq8jU0Q-e0oVoIc4A3_-C2Gdp63OYYtUxoTdiIro9oCBkKt2tT9u3eHT8w5nd_eZk-y5_UgquHTQW-PeBtnbl2ylFCKP8F3rxj7Q</recordid><startdate>19960601</startdate><enddate>19960601</enddate><creator>Adams, Bruce K</creator><creator>Fataar, Abdulbasier</creator><creator>Nizami, Mohammad A</creator><general>Soc Nuclear Med</general><general>Society of Nuclear Medicine</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>19960601</creationdate><title>Technetium-99m-Sestamibi Uptake in Myeloma</title><author>Adams, Bruce K ; Fataar, Abdulbasier ; Nizami, Mohammad A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h265t-22bd3f4a1386aaa1dbb350a2941feff4d390f74ef6d56bb16d97e513ae88a0593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Female</topic><topic>Humans</topic><topic>Hyperplasia</topic><topic>Immunoglobulin kappa-Chains - metabolism</topic><topic>Middle Aged</topic><topic>Multiple Myeloma - diagnostic imaging</topic><topic>Multiple Myeloma - immunology</topic><topic>Parathyroid Glands - diagnostic imaging</topic><topic>Parathyroid Glands - pathology</topic><topic>Radionuclide Imaging</topic><topic>Technetium Tc 99m Sestamibi</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adams, Bruce K</creatorcontrib><creatorcontrib>Fataar, Abdulbasier</creatorcontrib><creatorcontrib>Nizami, Mohammad A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection (ProQuest)</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database (ProQuest)</collection><collection>Biological Science Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of nuclear medicine (1978)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adams, Bruce K</au><au>Fataar, Abdulbasier</au><au>Nizami, Mohammad A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Technetium-99m-Sestamibi Uptake in Myeloma</atitle><jtitle>The Journal of nuclear medicine (1978)</jtitle><addtitle>J Nucl Med</addtitle><date>1996-06-01</date><risdate>1996</risdate><volume>37</volume><issue>6</issue><spage>1001</spage><epage>1002</epage><pages>1001-1002</pages><issn>0161-5505</issn><eissn>1535-5667</eissn><coden>JNMEAQ</coden><abstract>A number of reports describe how 99mTc-sestamibi detects benign and malignant primary and metastatic tumors. We report abnormal 99mTc-sestamibi uptake in nine sites in a 53-yr-old patient with histologically and biochemically proven IgG kappa-secreting myeloma. The 99mTc-sestamibi study was undertaken for an unrelated hyperparathyroidism.</abstract><cop>United States</cop><pub>Soc Nuclear Med</pub><pmid>8683291</pmid><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0161-5505 |
| ispartof | The Journal of nuclear medicine (1978), 1996-06, Vol.37 (6), p.1001-1002 |
| issn | 0161-5505 1535-5667 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_78174489 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Female Humans Hyperplasia Immunoglobulin kappa-Chains - metabolism Middle Aged Multiple Myeloma - diagnostic imaging Multiple Myeloma - immunology Parathyroid Glands - diagnostic imaging Parathyroid Glands - pathology Radionuclide Imaging Technetium Tc 99m Sestamibi |
| title | Technetium-99m-Sestamibi Uptake in Myeloma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T15%3A23%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Technetium-99m-Sestamibi%20Uptake%20in%20Myeloma&rft.jtitle=The%20Journal%20of%20nuclear%20medicine%20(1978)&rft.au=Adams,%20Bruce%20K&rft.date=1996-06-01&rft.volume=37&rft.issue=6&rft.spage=1001&rft.epage=1002&rft.pages=1001-1002&rft.issn=0161-5505&rft.eissn=1535-5667&rft.coden=JNMEAQ&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E25381907%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=219247702&rft_id=info:pmid/8683291&rfr_iscdi=true |